Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
40
ALVO Quote, Financials, Valuation and Earnings
Last price:
$8.76
Seasonality move
:
-1.43%
Day range:
$8.37 - $8.76
52-week range:
$7.35 - $13.70
Dividend yield:
0%
P/E ratio:
23.59x
P/S ratio:
4.25x
P/B ratio:
--
Volume:
318.9K
Avg. volume:
272K
1-year change:
-27.13%
Market cap:
$2.7B
Revenue:
$489.7M
EPS (TTM):
$0.37
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $66.6M | $36.8M | $83M | $91.4M | $489.7M | |
| Revenue Growth (YoY) | 108.71% | -44.8% | 125.79% | 10.12% | 435.56% | |
| Cost of Revenues | -- | -- | $64.1M | $160.9M | $185.3M | |
| Gross Profit | $66.6M | $36.8M | $18.9M | -$69.4M | $304.4M | |
| Gross Profit Margin | -- | -- | 22.8% | -75.93% | 62.16% | |
| R&D Expenses | $148.1M | $191M | $180.6M | $210.8M | $171.3M | |
| Selling, General & Admin | $58.9M | $84.1M | $183.4M | $73M | $61.5M | |
| Other Inc / (Exp) | -$53.7M | $200.8M | -$114.7M | -$166.2M | -$134.2M | |
| Operating Expenses | $204.2M | $272.2M | $365.4M | $285.4M | $234.7M | |
| Operating Income | -$137.5M | -$235.5M | -$346.4M | -$354.9M | $69.6M | |
| Net Interest Expenses | $100.5M | $114.5M | $90.5M | $130M | $153M | |
| EBT. Incl. Unusual Items | -$291.8M | -$149.2M | -$551.6M | -$651M | -$217.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$121.7M | -$47.7M | -$38.1M | -$99.3M | $14.3M | |
| Net Income to Company | -$170M | -$101.5M | -$513.6M | -$551.7M | -$231.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$170M | -$101.5M | -$513.6M | -$551.7M | -$231.9M | |
| Basic EPS (Cont. Ops) | -$1.54 | -$0.92 | -$2.60 | -$2.43 | -$0.87 | |
| Diluted EPS (Cont. Ops) | -$1.54 | -$0.92 | -$2.60 | -$2.43 | -$0.87 | |
| Weighted Average Basic Share | $110.7M | $110.7M | $197.7M | $227.3M | $267.9M | |
| Weighted Average Diluted Share | $243.6M | $110.7M | $197.7M | $227.3M | $267.9M | |
| EBITDA | -$177.9M | -$18M | -$453.8M | -$493.7M | -$32.3M | |
| EBIT | -$194.3M | -$36.2M | -$474.2M | -$517.9M | -$63.6M | |
| Revenue (Reported) | $66.6M | $36.8M | $83M | $91.4M | $489.7M | |
| Operating Income (Reported) | -$137.5M | -$235.5M | -$346.4M | -$354.9M | $69.6M | |
| Operating Income (Adjusted) | -$194.3M | -$36.2M | -$474.2M | -$517.9M | -$63.6M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $452K | $15.9M | $36.9M | $132.8M | |
| Revenue Growth (YoY) | -- | -- | 3409.74% | 132.3% | 260.27% | |
| Cost of Revenues | -- | $1.7M | $39.1M | $20M | $65.4M | |
| Gross Profit | -- | -$1.3M | -$23.2M | $16.9M | $67.3M | |
| Gross Profit Margin | -- | -286.73% | -146.44% | 45.85% | 50.71% | |
| R&D Expenses | -- | $47.1M | $50.9M | $49.9M | $38.2M | |
| Selling, General & Admin | -- | $24.2M | $22.2M | $15.5M | $18.6M | |
| Other Inc / (Exp) | -- | -$2.9M | -$2.9M | $6.5M | -$7.9M | |
| Operating Expenses | -- | $71M | $73M | $65.3M | $56.7M | |
| Operating Income | -- | -$72.3M | -$96.3M | -$48.4M | $10.6M | |
| Net Interest Expenses | -- | $19.9M | $206.4M | $183.3M | -- | |
| EBT. Incl. Unusual Items | -- | -$95.1M | -$305.6M | -$225.2M | $93.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -$18.2M | -$29.4M | -$6.4M | -$16.3M | |
| Net Income to Company | -- | -$77M | -$276.2M | -$218.7M | $109.7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -$77M | -$276.2M | -$218.7M | $109.7M | |
| Basic EPS (Cont. Ops) | -- | -$0.32 | -$1.24 | -$0.89 | $0.39 | |
| Diluted EPS (Cont. Ops) | -- | -$0.32 | -$1.24 | -$0.89 | $0.35 | |
| Weighted Average Basic Share | -- | $243.6M | $222.7M | $245.8M | $281.2M | |
| Weighted Average Diluted Share | -- | $243.6M | $222.7M | $245.8M | $313.4M | |
| EBITDA | -- | -$70.5M | -$93.1M | -$33.9M | $137.2M | |
| EBIT | -- | -$75.2M | -$98M | -$41.1M | $129M | |
| Revenue (Reported) | -- | $452K | $15.9M | $36.9M | $132.8M | |
| Operating Income (Reported) | -- | -$72.3M | -$96.3M | -$48.4M | $10.6M | |
| Operating Income (Adjusted) | -- | -$75.2M | -$98M | -$41.1M | $129M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | $98.4M | $112.4M | $585.6M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | $101.4M | $141.7M | $230.8M | |
| Gross Profit | -- | -- | -$3M | -$29.3M | $354.8M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | $184.3M | $209.8M | $159.6M | |
| Selling, General & Admin | -- | -- | $181.4M | $66.3M | $64.6M | |
| Other Inc / (Exp) | -- | $267.4M | -$114.7M | -$156.7M | -$148.7M | |
| Operating Expenses | -- | -- | $367.4M | $277.7M | $226.2M | |
| Operating Income | -- | -- | -$370.5M | -$307M | $128.6M | |
| Net Interest Expenses | -- | -- | $277M | $106.9M | -- | |
| EBT. Incl. Unusual Items | -- | -- | -$762.1M | -$570.7M | $101M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -$49.3M | -$76.4M | $4.5M | |
| Net Income to Company | -- | -- | -$712.8M | -$494.3M | $96.5M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -$712.8M | -$494.3M | $96.5M | |
| Basic EPS (Cont. Ops) | -- | -- | -$3.25 | -$2.08 | $0.41 | |
| Diluted EPS (Cont. Ops) | -- | -- | -$3.25 | -$2.08 | $0.37 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -$476.4M | -$434.5M | $138.9M | |
| EBIT | -- | -- | -$496.9M | -$461M | $106.5M | |
| Revenue (Reported) | -- | -- | $98.4M | $112.4M | $585.6M | |
| Operating Income (Reported) | -- | -- | -$370.5M | -$307M | $128.6M | |
| Operating Income (Adjusted) | -- | -- | -$496.9M | -$461M | $106.5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $452K | $15.9M | $36.9M | $132.8M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | $1.7M | $39.1M | $20M | $65.4M | |
| Gross Profit | -- | -$1.3M | -$23.2M | $16.9M | $67.3M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | $47.1M | $50.9M | $49.9M | $38.2M | |
| Selling, General & Admin | -- | $24.2M | $22.2M | $15.5M | $18.6M | |
| Other Inc / (Exp) | -- | -$2.9M | -$2.9M | $6.5M | -$7.9M | |
| Operating Expenses | -- | $71M | $73M | $65.3M | $56.7M | |
| Operating Income | -- | -$72.3M | -$96.3M | -$48.4M | $10.6M | |
| Net Interest Expenses | -- | $19.9M | $206.4M | $183.3M | -- | |
| EBT. Incl. Unusual Items | -- | -$95.1M | -$305.6M | -$225.2M | $93.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -$18.2M | -$29.4M | -$6.4M | -$16.3M | |
| Net Income to Company | -- | -$77M | -$276.2M | -$218.7M | $109.7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -$77M | -$276.2M | -$218.7M | $109.7M | |
| Basic EPS (Cont. Ops) | -- | -$0.32 | -$1.24 | -$0.89 | $0.39 | |
| Diluted EPS (Cont. Ops) | -- | -$0.32 | -$1.24 | -$0.89 | $0.35 | |
| Weighted Average Basic Share | -- | $243.6M | $222.7M | $245.8M | $281.2M | |
| Weighted Average Diluted Share | -- | $243.6M | $222.7M | $245.8M | $313.4M | |
| EBITDA | -- | -$70.5M | -$93.1M | -$33.9M | $137.2M | |
| EBIT | -- | -$75.2M | -$98M | -$41.1M | $129M | |
| Revenue (Reported) | -- | $452K | $15.9M | $36.9M | $132.8M | |
| Operating Income (Reported) | -- | -$72.3M | -$96.3M | -$48.4M | $10.6M | |
| Operating Income (Adjusted) | -- | -$75.2M | -$98M | -$41.1M | $129M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $31.7M | $17.6M | $66.4M | $11.2M | $51.4M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $583K | $29.4M | $33M | $41.3M | $160.2M | |
| Inventory | $9.6M | $39.1M | $71.5M | $74.4M | $127.9M | |
| Prepaid Expenses | $5.9M | $9.3M | $20.6M | $22M | $24M | |
| Other Current Assets | -- | -- | -- | -- | $48.1M | |
| Total Current Assets | $86.2M | $119.8M | $230.7M | $194.8M | $455M | |
| Property Plant And Equipment | $177M | $205.3M | $268.1M | $356.6M | $409.7M | |
| Long-Term Investments | $56.7M | $55.3M | $48.6M | $18.5M | -- | |
| Goodwill | $13.4M | $12.4M | $11.6M | $12.1M | $11.3M | |
| Other Intangibles | $6.3M | $21.5M | $25.7M | $19.1M | $20.6M | |
| Other Long-Term Assets | $10.8M | $11.8M | $31M | $28.4M | $3.6M | |
| Total Assets | $474.4M | $598M | $828.4M | $950.1M | $1.2B | |
| Accounts Payable | $12M | $28.6M | $49.2M | $80.6M | $67.1M | |
| Accrued Expenses | $16.4M | $34.5M | $36.6M | $56M | $52.8M | |
| Current Portion Of Long-Term Debt | $2.5M | $2.8M | $19.9M | $38M | $32.7M | |
| Current Portion Of Capital Lease Obligations | $5.5M | $7.3M | $5.2M | $9.7M | $9.5M | |
| Other Current Liabilities | -- | -- | -- | -- | $59.4M | |
| Total Current Liabilities | $51M | $111.8M | $167.3M | $261M | $193.4M | |
| Long-Term Debt | $565.4M | $398.1M | $744.7M | $922.1M | $1B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.3B | $733.6M | $1.4B | $1.9B | $1.6B | |
| Common Stock | $73K | $135K | $2.1M | $2.3M | $2.8M | |
| Other Common Equity Adj | -- | -- | $30.6M | $42.9M | $17.3M | |
| Common Equity | -$867.2M | -$135.6M | -$564.4M | -$932.5M | -$412.8M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -$867.2M | -$135.6M | -$564.4M | -$932.5M | -$412.8M | |
| Total Liabilities and Equity | $474.4M | $598M | $828.4M | $950.1M | $1.2B | |
| Cash and Short Terms | $31.7M | $17.6M | $66.4M | $11.2M | $51.4M | |
| Total Debt | $567.9M | $400.9M | $764.6M | $960.2M | $1.1B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | $115.8M | $64.8M | $38.5M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | $30M | $41.3M | $168.3M | |
| Inventory | -- | -- | $75.2M | $92.2M | $142.1M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | $31.8M | $62.9M | $49.5M | |
| Total Current Assets | -- | -- | $269.1M | $292.3M | $458.9M | |
| Property Plant And Equipment | -- | -- | $272.3M | $362.8M | $422.9M | |
| Long-Term Investments | -- | -- | $47.6M | $18.5M | -- | |
| Goodwill | -- | -- | $11.9M | $11.8M | $11.1M | |
| Other Intangibles | -- | -- | $14.5M | $19.4M | $21.5M | |
| Other Long-Term Assets | -- | -- | $27.2M | $27.3M | $3.6M | |
| Total Assets | -- | -- | $895.5M | $1.1B | $1.2B | |
| Accounts Payable | -- | -- | $29.8M | $50.2M | $67.9M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | $23M | $37.6M | $32.8M | |
| Current Portion Of Capital Lease Obligations | -- | -- | $5.2M | $11.2M | $11.1M | |
| Other Current Liabilities | -- | -- | $75.1M | $76M | $64.6M | |
| Total Current Liabilities | -- | -- | $160.3M | $246.8M | $265.8M | |
| Long-Term Debt | -- | -- | $770.7M | $940.6M | $1.1B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | $1.6B | $1.7B | $1.5B | |
| Common Stock | -- | -- | $2.3M | $2.6M | $2.8M | |
| Other Common Equity Adj | -- | -- | $37.8M | $38.9M | $17.4M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | -$655.8M | -$658.8M | -$302.3M | |
| Total Liabilities and Equity | -- | -- | $895.5M | $1.1B | $1.2B | |
| Cash and Short Terms | -- | -- | $115.8M | $64.8M | $38.5M | |
| Total Debt | -- | -- | $793.7M | $978.1M | $1.1B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$170M | -$101.5M | -$513.6M | -$551.7M | -$231.9M | |
| Depreciation & Amoritzation | $16.4M | $18.2M | $20.4M | $24.2M | $31.3M | |
| Stock-Based Compensation | -- | -- | $10.3M | $18M | $7.6M | |
| Change in Accounts Receivable | $10.1M | -$13.5M | -$13.2M | -$24.8M | -$164.2M | |
| Change in Inventories | -$3.3M | -$29.4M | -$32.4M | -$11.3M | -$50M | |
| Cash From Operations | -$74.3M | -$228.2M | -$312.4M | -$312.2M | -$236.8M | |
| Capital Expenditures | $12M | $40.6M | $49M | $46.5M | $57M | |
| Cash Acquisitions | -- | -- | -- | -- | $12M | |
| Cash From Investing | -$16.9M | -$40.6M | -$63.5M | -$46.3M | -$18.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $30M | $113.8M | $353.7M | $278.8M | $920.8M | |
| Long-Term Debt Repaid | -$9M | -$44.8M | -$95.9M | -$107.6M | -$768.8M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | $157.3M | -$13.1M | -$10M | |
| Cash From Financing | $55.4M | $254.8M | $424.9M | $301.3M | $297.3M | |
| Beginning Cash (CF) | $67.4M | $31.7M | $17.6M | $66.4M | $11.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$35.8M | -$14M | $49M | -$57.2M | $41.6M | |
| Ending Cash (CF) | $31.7M | $17.6M | $66.4M | $11.2M | $51.4M | |
| Levered Free Cash Flow | -$86.3M | -$268.8M | -$361.4M | -$358.7M | -$293.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -$77M | -$276.2M | -$218.7M | $109.7M | |
| Depreciation & Amoritzation | -- | $4.7M | $4.8M | $7.2M | $8.3M | |
| Stock-Based Compensation | -- | -- | -- | $2.8M | $1.3M | |
| Change in Accounts Receivable | -- | $27.9M | $3.8M | $5.5M | $27.5M | |
| Change in Inventories | -- | -$10.7M | -$3.8M | -$12.4M | -$14.9M | |
| Cash From Operations | -- | -$37.6M | -$86.1M | -$75.4M | $12.5M | |
| Capital Expenditures | -- | $13.2M | $13.9M | $4.6M | $23.4M | |
| Cash Acquisitions | -- | -- | -- | -- | $3M | |
| Cash From Investing | -- | -$13.2M | -$13.9M | -$3.5M | -$20.4M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $56.8M | $60.4M | -- | -- | |
| Long-Term Debt Repaid | -- | -$2.4M | -$52.3M | -$4M | -$5.8M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -$4.1M | -$5.7M | -- | |
| Cash From Financing | -- | $54.4M | $147.2M | $133.2M | -$5.8M | |
| Beginning Cash (CF) | -- | $17.6M | $66.4M | $11.2M | $51.4M | |
| Foreign Exchange Rate Adjustment | -- | -$15K | $2.2M | -$643K | $801K | |
| Additions / Reductions | -- | $3.6M | $47.2M | $54.3M | -$13.7M | |
| Ending Cash (CF) | -- | $21.1M | $115.8M | $64.8M | $38.5M | |
| Levered Free Cash Flow | -- | -$50.8M | -$100M | -$80M | -$10.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -$712.8M | -$494.3M | $96.5M | |
| Depreciation & Amoritzation | -- | -- | $20.6M | $26.6M | $32.4M | |
| Stock-Based Compensation | -- | -- | $10.3M | $20.9M | $6.1M | |
| Change in Accounts Receivable | -- | -- | -$37.3M | -$23.1M | -$142.3M | |
| Change in Inventories | -- | -- | -$25.5M | -$20M | -$52.4M | |
| Cash From Operations | -- | -- | -$360.9M | -$301.5M | -$148.9M | |
| Capital Expenditures | -- | $13.2M | $49.7M | $37.2M | $75.8M | |
| Cash Acquisitions | -- | -- | -- | -- | $15M | |
| Cash From Investing | -- | -- | -$64.2M | -$35.9M | -$35.8M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | $357.3M | $218.4M | -- | |
| Long-Term Debt Repaid | -- | -- | -$145.8M | -$59.3M | -$770.7M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | $153.1M | -$14.7M | -- | |
| Cash From Financing | -- | -- | $517.7M | $287.3M | $158.3M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | $92.6M | -$50.1M | -$26.4M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -$410.6M | -$338.7M | -$224.6M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -$77M | -$276.2M | -$218.7M | $109.7M | |
| Depreciation & Amoritzation | -- | $4.7M | $4.8M | $7.2M | $8.3M | |
| Stock-Based Compensation | -- | -- | -- | $2.8M | $1.3M | |
| Change in Accounts Receivable | -- | $27.9M | $3.8M | $5.5M | $27.5M | |
| Change in Inventories | -- | -$10.7M | -$3.8M | -$12.4M | -$14.9M | |
| Cash From Operations | -- | -$37.6M | -$86.1M | -$75.4M | $12.5M | |
| Capital Expenditures | -- | $13.2M | $13.9M | $4.6M | $23.4M | |
| Cash Acquisitions | -- | -- | -- | -- | $3M | |
| Cash From Investing | -- | -$13.2M | -$13.9M | -$3.5M | -$20.4M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $56.8M | $60.4M | -- | -- | |
| Long-Term Debt Repaid | -- | -$2.4M | -$52.3M | -$4M | -$5.8M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -$4.1M | -$5.7M | -- | |
| Cash From Financing | -- | $54.4M | $147.2M | $133.2M | -$5.8M | |
| Beginning Cash (CF) | -- | $17.6M | $66.4M | $11.2M | $51.4M | |
| Foreign Exchange Rate Adjustment | -- | -$15K | $2.2M | -$643K | $801K | |
| Additions / Reductions | -- | $3.6M | $47.2M | $54.3M | -$13.7M | |
| Ending Cash (CF) | -- | $21.1M | $115.8M | $64.8M | $38.5M | |
| Levered Free Cash Flow | -- | -$50.8M | -$100M | -$80M | -$10.8M | |
Get ALVO Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ALVO
Sector
P/E ratio
23.59x
24.07x
PEG ratio
-0.13x
0.00x
P/B ratio
--
1.81x
Price / LTM sales
4.25x
1.67x
Growth Metrics
ALVO
Sector
Revenue growth
260.27%
4.06%
Earnings growth
-67.06%
7.49%
Revenue (5-year growth)
72.65%
8.01%
Earnings forecast
-$0.00
-$0.20
Profitability
ALVO
Sector
Profitability FY 2024
$304.4M
$47.5M
Return on invested capital
16.62%
-16.26%
Return on assets
8.28%
-13.27%
Return on equity
--
-18.61%
Earnings Date
Last Earnings Date
May
8
Next Earnings Date
Aug
13
Estimated Next Earnings Date
Aug
7
Balance Sheet
ALVO
Sector
Total cash
$38.5M
$35.7M
Short term investments
--
$29.7M
Total assets
$1.2B
$106.9M
Long term debt
$1.1B
$7.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
71
PGY alert for Jul 18
Pagaya Technologies [PGY] is up 4.92% over the past day.
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 0.03% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 9.69% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
